Cardiol Therapeutics Inc. (CRDL) vs Protara Therapeutics, Inc. (TARA)
A side-by-side comparison of Cardiol Therapeutics Inc. and Protara Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDL
Cardiol Therapeutics Inc.
$1.31HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TARA
Protara Therapeutics, Inc.
$2.56HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRDL vs TARA
growth of $100 · dividends reinvested · last 8yCRDL -64.7% (-12.2%/yr)TARA -97.3% (-36.4%/yr)CRDL compounded faster over this window
Log scale — wide-divergence pair
CRDL TARA
CRDL vs TARA: by the numbers
- •CRDL is the larger company ($151M vs $144M market cap).
Metrics side by side
Valuation
| Metric | CRDL | TARA |
|---|---|---|
| P/B ratio | 8.92 | 0.89 |
Profitability
| Metric | CRDL | TARA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -155.34% | -43.40% |
| ROIC | -165.56% | -47.18% |
Growth (annualized)
| Metric | CRDL | TARA |
|---|---|---|
| Total return CAGR (5Y) | -18.36% | -16.45% |
Frequently asked
- How have CRDL and TARA total returns compared?
- Over the past 5 years, CRDL delivered -18.36% and TARA delivered -16.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.